News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
SENTRY study – investigating the safety and efficacy of the combination of selinexor plus ruxolitinib in myelofibrosis
Photo from Icahn School of Medicine at Mount Sinai/X
Aug 12, 2024, 13:49

SENTRY study – investigating the safety and efficacy of the combination of selinexor plus ruxolitinib in myelofibrosis

Icahn School of Medicine at Mount Sinai shared on X:

“The SENTRY study, led by Dr. John Mascarenhas, is investigating the safety and efficacy of the combination of selinexor (Xpovio) plus ruxolitinib (Jakafi) for the treatment of patients with JAK inhibitor treatment-naive myelofibrosis.”

Read further.
Source: Icahn School of Medicine at Mount Sinai/X

cancer Icahn School of Medicine at Mount Sinai John Mascarenhas myelofibrosis OncoDaily Oncology ruxolitinib (Jakafi) selinexor (Xpovio) SENTRY SENTRY trial
Special Coverage
Blog
Feb 21, 2025, 12:39
Clinical Trials in Europe: Key Trends and Issues - Lung Cancer Europe
Blog
Feb 21, 2025, 12:29
The launch of the Access Cancer Treatment for Children initiative - Childhood Cancer International
Blog
Feb 21, 2025, 11:52
Zainab Shinkafi-Bagudu: Exploring collaborations in cancer care with the Indian High Commission in Abuja
Blog
Feb 21, 2025, 11:51
Integrative medicine for cancer-related pain and anxiety/depression - Society for Integrative Oncology
Insight
Feb 21, 2025, 11:40
Zoë Mullan: The launch of our much-anticipated Commission on medical oxygen security
Science
Feb 21, 2025, 11:36
Myeloma Paper of the Day, February 21st, suggested by Robert Orlowski
Dialogues
Feb 21, 2025, 11:29
HPV Self-Collection for Cervical Cancer: Dr. Kay's Insights
Science
Feb 21, 2025, 11:03
George Vlachogiannis: A growing CRC burden among younger individuals in high socio-demographic index regions
Blog
Feb 21, 2025, 11:02
Divya Sachdev: Building a future where every child, no matter where they live, has a fair chance at survival
Blog
Feb 21, 2025, 10:55
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology
Blog
Feb 21, 2025, 10:45
Saurabh Zanwar: Clonal plasma cell proportion in the S-phase in multiple myeloma
Blog
Feb 21, 2025, 10:37
Cihangir Akyol: A comprehensive review on colorectal ESD outcomes by Lumir Kunovsky